San Diego-primarily based Viking Therapeutics marked alone as a significant competitor from the weight loss drug current market in February following revealing promising info from a mid-stage trial of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when given for a weekly injection As well as in March t